Virax Biolabs Group Limited (VRAX)
VRAX Stock Price Chart
Explore Virax Biolabs Group Limited interactive price chart. Choose custom timeframes to analyze VRAX price movements and trends.
VRAX Company Profile
Discover essential business fundamentals and corporate details for Virax Biolabs Group Limited (VRAX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
21 Jul 2022
Employees
19.00
Website
https://viraxbiolabs.comCEO
James Foster
Description
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.
VRAX Financial Timeline
Browse a chronological timeline of Virax Biolabs Group Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Dec 2026
EPS estimate is -$0.10, while revenue estimate is $10.00m.
Upcoming earnings on 2 Dec 2026
EPS estimate is -$1.75, while revenue estimate is $10.82k.
Earnings released on 1 Jul 2026
Revenue for the quarter reached $10.82k , beating expectations by +726.59%.
Stock split effective on 26 Jun 2026
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 Nov 2025
EPS came in at -$19.00 falling short of the estimated -$8.50 by -123.53%, while revenue for the quarter reached $1.38k , missing expectations by -99.99%.
Earnings released on 2 Jul 2025
EPS came in at -$42.75 , while revenue for the quarter reached $79.92k , missing expectations by -98.40%.
Earnings released on 20 Nov 2024
EPS came in at -$41.00 , while revenue for the quarter reached $76.50k , missing expectations by -97.45%.
Earnings released on 20 Nov 2024
EPS came in at -$0.49 , while revenue for the quarter reached $2.00k .
Earnings released on 20 Aug 2024
EPS came in at -$0.65 , while revenue for the quarter reached $2.80k , missing expectations by -99.72%.
Earnings released on 12 Jan 2024
EPS came in at -$31.00 , while revenue for the quarter reached $5.76k , missing expectations by -98.56%.
Stock split effective on 18 Dec 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Jun 2023
EPS came in at -$25.50 , while revenue for the quarter reached -$92.87k , missing expectations by -146.43%.
Earnings released on 2 Feb 2023
EPS came in at -$12.25 .
VRAX Stock Performance
Access detailed VRAX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
